Kefir's effect in reducing chemotherapy side effects in colon cancer patients
Design
Clinical trial with control group, parallel groups, randomized, and phase 3 on 40 patients. Random Allocation software was used for randomization.
Settings and conduct
This study investigates the effect of kefir on chemotherapy complications in patients at Imam Sajad Ramsar Hospital. For the kefir group, kefir consumption will begin at the time of the tenth chemotherapy session for six weeks. Until the end of the twelfth chemotherapy session, one glass (equivalent to 250 cc) will be consumed every other day, four days a week. Kefir is not used in the control group. All participants in both groups will be asked questions about side effects related to chemotherapy treatment, and the impact of kefir in the intervention group will be evaluated compared to the control group.
Participants/Inclusion and exclusion criteria
Inclusion criteria: patients with stage 3 and/or 4 colon cancer who have undergone 12 chemotherapy sessions with FOLFOX injectable drugs. Exclusion criteria: consumption of probiotic, prebiotic, and synbiotic products within the past three months; alcohol consumption; patients who cannot complete the study period; and being lactose intolerant.
Intervention groups
Kefir group: kefir consumption
Control group: no kefir consumption
Evaluation of Kefir's Effects on Chemotherapy Complications in Colon Cancer Patients
Public title
Effect of kefir on the side effects of colon cancer chemotherapy
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients with stages 3 and/or 4 colon cancer treated with injectable FOLFOX chemotherapy for 12 sessions
Exclusion criteria:
Consumption of probiotic, prebiotic, or synbiotic products in the last three months
Alcohol consumption
Patients incapable of completing the study period
Lactose malabsorption
Age
From 18 years old
Gender
Both
Phase
3
Groups that have been masked
No information
Sample size
Target sample size:
40
Randomization (investigator's opinion)
Randomized
Randomization description
A block classification method will be used to allocate samples into two groups. The blocking process will be done using random allocation software. Based on random numbers generated by this software, samples will be analyzed. A control group and a kefir group will be studied according to this method.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ramsar Campus ethics commitee
Street address
Imam street, behind Imam sajad hospital
City
Ramsar
Province
Mazandaran
Postal code
4691710001
Approval date
2022-10-18, 1401/07/26
Ethics committee reference number
IR.MAZUMS.RIB.REC.1401.051
Health conditions studied
1
Description of health condition studied
Colon cancer
ICD-10 code
C18
ICD-10 code description
Malignant neoplasm of colon
Primary outcomes
1
Description
Diarrhea
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
2
Description
Constipation
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
3
Description
Xerostomia
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
4
Description
Sleep disorders
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
5
Description
Nausea
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
6
Description
Weight loss
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
7
Description
Anorexia
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
8
Description
Flatulence
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
9
Description
Dysgeusia
Timepoint
At the beginning and end of the intervention
Method of measurement
Completing the questionnaire and being evaluated in person and by phone
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: 20 patients with colon cancer in stages 3 and/or 4 who received injectable treatment with FOLFOX (Folinic acid, Fluorouracil, and Oxaliplatin) in 12-session chemotherapy courses. Kefir grains, industrially produced by Iran Ferment Company, Tehran, Iran, are added to milk pasteurized at 90-95°C for 10-15 minutes and cooled to 25-30°C. After the fermentation period, which lasts 24-48 hours, the seeds are separated by filtration. Kefir is stored in a container for one day, and then it is divided into bottles and stored in a refrigerator at 4 degrees Celsius. And will be used within two weeks. All kefirs prepared from the exact kefir grain are prepared under the same fermentation conditions to ensure that identical probiotics are present in the prepared kefirs. Patients will take one glass equivalent to 250 CC for six weeks at the same time as the tenth chemotherapy session. They will do this four days a week and continue until the end of the twelfth chemotherapy session.
Category
Treatment - Other
2
Description
Control group: 20 patients with colon cancer in stages 3 and/or 4 who are treated with FOLFOX (folinic acid, fluorouracil, and oxaliplatin) in 12-session chemotherapy courses.
Category
Treatment - Other
Recruitment centers
1
Recruitment center
Name of recruitment center
Imam Sajad Hospital, Ramsar, Mazandaran, Iran
Full name of responsible person
Dr Shahrbanoo Keyhanian
Street address
Imam Street
City
Ramsar
Province
Mazandaran
Postal code
4691710001
Phone
+98 11 5522 2031
Email
b.aghaee@hotmail.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Mazandaran University of Medical Sciences
Full name of responsible person
Mahsa Narenji
Street address
Imam st. Behind Imam Sajad Hospital. Ramsar Campus
City
Ramsar
Province
Mazandaran
Postal code
4691710001
Phone
+98 11 5509 1125
Email
b.aghaee@hotmail.com
Grant name
Mazandaran University of Medical Sciences
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mazandaran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Mazandaran University of Medical Sciences
Full name of responsible person
Bahareh Lashtoo Aghaee
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Microbiology
Street address
Imam st. Behind Imam Sajad Hospital, Ramsar campus